Publication stageIn Press Accepted Manuscript
Conflicts of interest:
These authors disclose the following: Christopher W.J. McChalicher, Mary-Jane Lombardo PhD, Barbara H. McGovern MD, John G. Aunins PhD, Elizabeth Halvorsen PhD, Sanabel Almomani, and David S. Ege PhD are all current employees and shareholders of Seres Therapeutics. Gregory J. McKenzie PhD and Brian Schuster are former employees of Seres Therapeutics. Sahil Khanna MBBS receives research support from Rebioitx / Ferring, Vedanta, Finch, Seres and Pfizer and also serves as a consultant for ProbioTech, Takeda, Niche and Immuron.
Data transparency statement: Data, analytic methods, and study materials will not be available.
Reporting Guidelines: Not applicable
Ethical Statement: The corresponding author, on behalf of all authors, jointly and severally, certifies that their institution has approved the protocol for any investigation involving humans or animals and that all experimentation was conducted in conformity with ethical and humane principles of research.
Funding: This research was sponsored by Seres Therapeutics.
User licenseCreative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0) |
For non-commercial purposes:
- Read, print & download
- Redistribute or republish the final article
- Text & data mine
- Translate the article (private use only, not for distribution)
- Reuse portions or extracts from the article in other works
- Sell or re-use for commercial purposes
- Distribute translations or adaptations of the article
Elsevier's open access license policy